Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

224.81 +0.46 (+0.21%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AbbVie

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

86 87 Next >

NEXGEL Inc. Equity Warrants: A High-Stakes Bet on Future Profitability Amidst Rapid Growth

September 27, 2025

Langhorne, PA – September 27, 2025 – Investors in NEXGEL Inc. (NASDAQ: NXGL), a company at the forefront of hydrogel technology, are closely watching the trajectory of its equity warrants (NXGLW)....

Via MarketMinute

Topics Intellectual Property

Decoding AbbVie's Options Activity: What's the Big Picture? ↗

September 26, 2025

Investors with a lot of money to spend have taken a bearish stance on AbbVie (NYSE: ABBV). And retail traders should know. We noticed this today when the trades showed up on publicly available options...

Via Benzinga

Pharma Tariffs Back In Spotlight On New Trump Threat ↗

September 26, 2025

President Donald Trump threatened 100% tariffs on some drug imports.

Via Investor's Business Daily

Topics ETFs Government World Trade

How Do Investors Really Feel About AbbVie? ↗

September 17, 2025

Via Benzinga

AbbVie Logs Best Day In Over 7 Months As Wall Street Cheers Rinvoq Patent Deal Pushing Generics To 2037 ↗

September 12, 2025

Via Stocktwits

Topics Intellectual Property

AbbVie Stock Touches Record High After Company Dismisses Generic Competition For Rinvoq Till 2037: Wells Fargo Terms It A ‘Big Win’ ↗

September 11, 2025

Via Stocktwits

Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet ↗

September 26, 2025

Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de

Via Benzinga

Topics Government World Trade

3 Top Dividend Stocks to Buy and Hold Forever ↗

September 25, 2025

These blue chip dividend stocks offer both income and growth potential.

Via The Motley Fool

Topics Intellectual Property

Where Will AbbVie Be in 5 Years? ↗

September 25, 2025

This big pharmaceutical company should be significantly bigger five years from now.

Via The Motley Fool

Topics Earnings Economy Government

Novartis, AbbVie Face Legal Defeat Over 340B Contract Pharmacies ↗

September 24, 2025

A judge upholds Maine's contract pharmacy law, rejecting drugmakers' claims that it conflicts with federal rules governing the 340B drug discount program.

Via Benzinga

STRATA Skin Sciences Soars as Landmark Study Reveals Superior Vitiligo Treatment Efficacy

September 23, 2025

STRATA Skin Sciences Inc. (NASDAQ: SSKN) witnessed a dramatic surge in its stock price today, climbing 51.18% following the publication of a groundbreaking peer-reviewed study. The research highlights...

Via MarketMinute

Topics Intellectual Property

The Magnificent 7 Boom Just Triggered A Dot-Com Era Warning ↗

September 23, 2025

The Magnificent Seven tech giants are now worth $21 trillion—8x more than top health care stocks, echoing dot-com bubble extremes.

Via Benzinga

1 Top Dividend Stock to Buy and Hold Forever ↗

September 22, 2025

The stock has outperformed the broader market since its 2013 IPO, and can still do so over the long run.

Via The Motley Fool

Topics Economy Initial Public Offering Intellectual Property

Inflation's Lingering Shadow: Long-Term Expectations Rise Amidst Fed Rate Cuts

September 22, 2025

The financial markets are currently navigating a perplexing economic landscape where long-term inflation expectations are on the rise, even as the Federal Reserve initiates interest rate cuts. In...

Via MarketMinute

Topics Bonds ETFs Economy

Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance

September 22, 2025

Johnson & Johnson (NYSE: JNJ), the global healthcare titan, has once again underscored its formidable market position and unwavering commitment to shareholder value, reporting a robust second quarter...

Via MarketMinute

Topics Artificial Intelligence Intellectual Property

What Is One of the Best Pharmaceutical Stocks to Buy Right Now? ↗

September 22, 2025

There aren't many companies in the industry that offer an excellent combination of growth and income.

Via The Motley Fool

Topics Intellectual Property

Forever Dividend Stocks: 3 Income Stocks I Never Plan to Sell ↗

September 22, 2025

Never say never? Maybe not with these great dividend stocks.

Via The Motley Fool

Topics Intellectual Property

Johnson & Johnson Unleashes Triple Threat: Bladder Cancer Breakthrough, Psoriasis Game-Changer, and Myasthenia Gravis Milestone Signal New Pharma Era

September 19, 2025

Johnson & Johnson (NYSE: JNJ) is making significant waves in the pharmaceutical landscape, announcing a trio of pivotal developments that underscore its robust pipeline and strategic focus on unmet...

Via MarketMinute

Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes

September 19, 2025

Eli Lilly and Company (NYSE: LLY) is making significant waves in the oncology landscape with a series of major announcements concerning two of its innovative cancer therapies: Olomorasib and Jaypirca...

Via MarketMinute

3 Unstoppable Dividend Stocks to Buy If There's a Stock Market Sell-Off ↗

September 19, 2025

Everything is going great for the stock market right now. But a plot twist could be on the way.

Via The Motley Fool

Topics Economy

Oruka Therapeutics, Up 20%, Is Trying To Take On AbbVie's Biggest Moneymaker ↗

September 17, 2025

Shares skyrocketed after the company said its drug has a half-life of about 100 days.

Via Investor's Business Daily

This Workday Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday ↗

September 17, 2025

Via Benzinga

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields ↗

September 17, 2025

Via Benzinga

$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today ↗

September 16, 2025

Via Benzinga

3 No-Brainer Dividend Stocks to Buy in September ↗

September 13, 2025

The attraction of these dividend stocks isn't limited to their dividends.

Via The Motley Fool

Topics Intellectual Property

1 Green Flag for AbbVie (ABBV) Stock Right Now ↗

September 12, 2025

Dividends are powerful portfolio boosters, and AbbVie is a dividend dynamo.

Via The Motley Fool

Topics Intellectual Property

Texas Rep. Julie Johnson Sold Up to $885K Worth of 3M Stock ↗

September 12, 2025

Via Benzinga

The Best Stocks to Invest $50,000 In Right Now ↗

September 12, 2025

These stocks have what it takes to succeed over the long run.

Via The Motley Fool

Topics Artificial Intelligence Government Intellectual Property

Why AbbVie (ABBV) Stock Is Trading Up Today

September 11, 2025

Shares of pharmaceutical company AbbVie (NYSE:ABBV) jumped 4.4% in the morning session after the company announced it settled litigation with generic drug manufacturers to extend patent protection for...

Via StockStory

Topics Intellectual Property

Why AbbVie Stock Is Jumping Today ↗

September 11, 2025

AbbVie's growth prospects are now more secure thanks to its latest news.

Via The Motley Fool

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

86 87 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

AbbVie (NY:ABBV)

Headline News about AbbVie

Starting at $3.75/week.

Subscribe Today